Diverse Health Moves: Drug Pricing, Research Grants, and Global Aid
Published on: Dec. 31, 2025, 2:27 a.m. | Source: Devdiscourse
Current health news covers Novo and Lilly reducing obesity drug prices in China, a lawsuit-induced review of NIH research grants by the Trump administration, Genmab halting cancer therapy development, and a measles outbreak in South Carolina. Additionally, there's insight into weight-loss drug markets, Ultragenyx's failed bone disease drug, asylum denial on public health grounds, and substantial US funding for rural and global health initiatives.
